Skip to main navigation Skip to search Skip to main content

Estudio del sustrato neuropatológico y las bases moleculares en el espectro de la esclerosis lateral amiotrófica - demencia frontotemporal

    Student thesis: Doctoral thesis

    Abstract

    Although amyotrophic lateral sclerosis (ALS) has traditionally been considered a disease exclusively affecting the motor system, it is now recognized as part of a continuous spectrum with frontotemporal dementia (FTD). From a clinical perspective, it has been reported that up to 50% of ALS patients exhibit associated cognitive and behavioural symptoms, with 10-15% meeting the diagnostic criteria for FTD. Furthermore, these two neurodegenerative entities frequently share neuropathological substrates and genetic bases. However, the aetiology and pathophysiology of the disease remain poorly understood, as do the precise degree and frequency of overlap between the two conditions and their correlation with the molecular substrate within this disease continuum. The first article included in this doctoral thesis describes the phenotypic, neuropathological, and genetic characteristics of an extensive cohort of patients with neuropathologically confirmed motor neuron disease (MND) from the Neurological Tissue Bank at Hospital Clínic - FRCB - IDIBAPS, using retrospective data collection. In this series of 124 patients, a 35.5% frequency of neuropathological changes compatible with frontotemporal lobar degeneration (FTLD) is reported, which is higher than in previous series. Additionally, it highlights the significant heterogeneity in various aspects (clinical-phenotypic, genetic, and neuropathological) of the MND-FTLD spectrum, particularly in cases with concomitant FTLD. The study emphasises the undetected clinical aspects at both ends of the spectrum, revealing findings that went unnoticed during life and contributing to a precise definition of the forms and boundaries of the spectrum. This underscores the need for tools that enable precise in-life categorization of patients based on molecular criteria. Furthermore, the study highlights the necessity of close collaboration between neuromuscular and cognitive disorder units for a comprehensive approach to this pathology. The second article of this thesis describes a mutation in the ARPP21 gene as a cause of ALS in 10 patients from seven unrelated families originating from a small geographic area in the southeast of La Rioja (Spain), where conventional genetic testing had failed to identify causal mutations. Following the detection of an unexpected regional increase in cases, particularly familial ALS, a genomic study of several patients was conducted, identifying the p.Pro529Leu variant in ARPP21, an RNA-binding protein involved in RNA metabolism and stress granule formation, which was absent from population databases. This article supports the causal role of ARPP21 mutations in ALS pathogenesis and underscores the importance of this pathway in the disease's pathophysiology, suggesting a potential specific therapeutic target. Additionally, it proposes an innovative strategy for identifying causal genetic alterations in the disease. In summary, this doctoral thesis aims to contribute to the comprehensive description and characterization of the MND-FTLD spectrum, as well as to deepen our understanding of the disease's pathophysiology, substrate, and molecular bases, specifically its genetic foundations and the involvement of new implicated genes.
    Date of Award14 Feb 2025
    Original languageSpanish
    SupervisorRicardo Rojas Garcia (Director)

    Cite this

    '